Inventor · disambiguated record
Masaaki Kageyama
Also filed as: KAGEYAMA MASAAKI
5 granted patents·9 pending applications·80 citations·filing 1997–2016
78Inventor score
Files withSANTEN PHARMACEUTICAL CO LTD4ASAHI GLASS CO LTD2KINOSHITA SHIGERU2CEPHALON INC1OOHASHI KOUJI1
Top patents by PatentIndex Score
14 records- 0182US5886035ADifluoroprostaglandin derivatives and their useASAHI GLASS CO LTD·Filed 1997·Granted Mar 23, 1999·55 cites·14 claims
- 0266US8431345B2Method for determination of progression risk of glaucomaKINOSHITA SHIGERU·Filed 2008·Granted Apr 30, 2013·0 cites·11 claims
- 0359US5985920ADifluoroprostaglandin derivatives and their useASAHI GLASS CO LTD·Filed 1998·Granted Nov 16, 1999·15 cites·52 claims
- 0459US2013210668A1Method for determination of progression risk of glaucomaKINOSHITA SHIGERU·Filed 2013·Application pending·0 cites
- 0557US2013012408A1Method for determination of onset risk of glaucomaSHIGERU KINOSHITA·Filed 2012·Application pending·0 cites
- 0652US2004086511A1Neuronal gene expression patternsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 0752US2003013701A1Agent for treating ophthalmopathyFiled 2002·Application pending·0 cites
- 0848US2009253765A1Angiogenesis Inhibitor Containing Amine Derivative as Active IngredientSANTEN PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
- 0947US6451787B1Remedies for ocular diseasesCEPHALON INC·Filed 1999·Granted Sep 17, 2002·10 cites·7 claims
- 1045US10166217B2Fungal keratitis prophylactic or therapeutic agentSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 1, 2019·0 cites·13 claims
- 1142US2011160267A1Method of treating diabetic retinopathySANTEN PHARMACEUTICAL CO LTD·Filed 2011·Application pending·0 cites
- 1242US2011160262A1Method of treating retinal vein occlusionSANTEN PHARMACEUTICAL CO LTD·Filed 2011·Application pending·0 cites
- 1333US2009088472A1Protective Agent for Neuronal Cell Comprising Amidino Derivative as Active IngredientOOHASHI KOUJI·Filed 2006·Application pending·0 cites
- 1419US2011319463A1Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredientsSASAOKA MASAAKI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masaaki Kageyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →